EUVIMEDEUVIMED entdecken
KohortenstudieOpen Access

NT‐proBNP and All‐Cause and Cardiovascular Mortality in US Adults: A Prospective Cohort Study

Justin B Echouffo-Tcheugui iD, Sui Zhang iD, Natalie Daya iD, John W McEvoy iD, Olive Tang iD, Stephen P Juraschek iD, Chiadi E Ndumele, Josef Coresh iD, Robert H Christenson, Elizabeth Selvin iD

Journal of the American Heart Association · 06.06.2023 · 12 (11)

DOI: 10.1161/jaha.122.029110 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift Journal of the American Heart Association, erschienen am 06.06.2023. Verfasst von Justin B Echouffo-Tcheugui und 9 weiteren Autor:innen. Beteiligte Einrichtung: Division of Endocrinology, Diabetes and Metabolism, Department of Medicine Johns Hopkins University Baltimore MD. Hauptthemen laut MEDLINE: Natriuretic Peptide, Brain, Cardiovascular Diseases. Die Arbeit wurde bisher 44-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NHLBI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

NT‐proBNP (N‐terminal pro‐B‐type natriuretic peptide) is strongly associated with mortality in patients with heart failure. Prior studies, primarily in middle‐aged and older populations, have suggested that NT‐proBNP has prognostic value in ambulatory adults. Methods and Results We conducted a prospective cohort analysis of adults, aged ≥20 years, in the nationally representative 1999 to 2004 National Health and Nutrition Examination Survey, to characterize the association of NT‐proBNP with mortality in the general US adult population overall and by age, race and ethnicity, and body mass index. We used Cox regression to characterize associations of NT‐proBNP with all‐cause and cardiovascular disease (CVD) mortality through 2019, adjusting for demographics and cardiovascular risk factors. We included 10 645 individuals (mean age, 45.7 years; 50.8% women; 72.8% White adults; 8.5% with a self‐reported history of CVD). There were 3155 deaths (1009 CVD‐related) over a median 17.3 years of follow‐up. Among individuals without prior CVD, elevated NT‐proBNP (≥75th percentile [81.5 pg/mL] versus 0.05).

Conclusions

In a representative sample of the US adult population, NT‐proBNP was an important independent risk factor for all‐cause and CVD mortality. NT‐proBNP may be useful for monitoring risk in the general adult population.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Natriuretic Peptide, BrainCardiovascular DiseasesMiddle AgedHumansAdultFemaleAgedMaleProspective StudiesBiomarkersNutrition SurveysPrognosisPeptide Fragments

Stichwörter der Autor:innen

biomarkersbraincardiovascular diseaseepidemiologymortalitynatriuretic peptideprevention

Substanzen

pro-brain natriuretic peptide (1-76)Natriuretic Peptide, BrainBiomarkersPeptide Fragments

Autor:innen und Institutionen

  • Division of Endocrinology, Diabetes and Metabolism, Department of Medicine Johns Hopkins University Baltimore MD.
  • Department of Epidemiology and the Welch Center for Prevention, Epidemiology, and Clinical Research Johns Hopkins Bloomberg School of Public Health Baltimore MD.
  • Division of Cardiology and National Institute for Prevention and Cardiovascular Health National University of Ireland Galway Ireland.
  • Johns Hopkins School of Medicine Johns Hopkins University Baltimore MD.
  • Division of General Medicine, Beth Israel Deaconess Medical Center Harvard Medical School Boston MA.
  • Division of Cardiology, Department of Medicine Johns Hopkins University Baltimore MD.

ORCID-Profile: Justin B Echouffo-Tcheugui, Sui Zhang, Natalie Daya, John W McEvoy, Olive Tang, Stephen P Juraschek, Josef Coresh, Elizabeth Selvin

Förderung

  • NHLBI NIH HHS

Zitieren

APA

Echouffo-Tcheugui, J. B., Zhang, S., Daya, N., McEvoy, J. W., Tang, O., Juraschek, S. P., Ndumele, C. E., Coresh, J., Christenson, R. H., & Selvin, E. (2023). NT‐proBNP and All‐Cause and Cardiovascular Mortality in US Adults: A Prospective Cohort Study. Journal of the American Heart Association, 12(11). https://doi.org/10.1161/jaha.122.029110

Vancouver

Echouffo-Tcheugui JB, Zhang S, Daya N, McEvoy JW, Tang O, Juraschek SP, et al. NT‐proBNP and All‐Cause and Cardiovascular Mortality in US Adults: A Prospective Cohort Study. Journal of the American Heart Association. 2023;12(11). doi:10.1161/jaha.122.029110

BibTeX
@article{EchouffoTcheugui2023,
  author = {Echouffo-Tcheugui, Justin B and Zhang, Sui and Daya, Natalie and McEvoy, John W and Tang, Olive and Juraschek, Stephen P and Ndumele, Chiadi E and Coresh, Josef and Christenson, Robert H and Selvin, Elizabeth},
  title = {NT‐proBNP and All‐Cause and Cardiovascular Mortality in US Adults: A Prospective Cohort Study},
  journal = {Journal of the American Heart Association},
  year = {2023},
  volume = {12},
  number = {11},
  doi = {10.1161/jaha.122.029110}
}
Kostenlos starten →